INTRODUCTION
Sudden hearing loss (SHL) is defined ashearing loss determined above 30 dB at three consecutive frequencies in 3 days. Its incidence varies between 5 and 20 per 100,000 in adult patients. However, its exact incidence is unknown in a pediatric population. Its etiology can be detected in only 10-15% of patients with SHL. These causes generally include cochlear artery perfusion problems and infectious and autoimmune causes. SHL with undetectable etiological factors is defined as idiopathic sudden hearing loss (ISHL) [1, 2] . Recently, it has been focused on chronic inflammation in patients with ISHL. Chronic inflammation causes microvascular injury and increases the risk of ischemia [3] . In studies on cardiovascular diseases, the neutrophil-to-lymphocyte ratio (NLR) was found to be an important prognostic factor [4] . Besides, the platelet-to-lymphocyte ratio (PLR) has been to be related to a poor prognosis in patients with peripheral arterial disease [5] . There are studies in the literature that show a relationship between SHL prognosis in adults and the NLR and PLR [6] .
In this study, we investigated the relationship of the NLR and PLR in the prognosis of pediatric patients with ISHL by comparing the NLR and PLR in blood samples and pure-tone thresholds of pre-and post-treatment audiograms.
MATERIALS and METHODS
A total of 13 males and 8females younger than19 years with ISHL were retrospectively examined between January 2008 and August 2016 in our clinic. In all patients, hearing loss was followed up unilaterally. Besides, there was a control group consisting of 12 males and 12 females who did not have any problem and who had normal hearing functions.
The average age of the patients was 13.7±3.2 years, and the average age of those in the control group was 14.8±2.9 years. Inclusion criteria were as follows: starting of hearing loss within 72 hours; detection of pure-tone threshold over 30 dB hearing loss in three consecutive frequencies at audiogram; admission within 1 week after the initiation of the disease; not using steroid treatment before; not having acute inflammation, infection, ear surgery, trauma, and barotrauma in the last 4 weeks; not having cerebellopontine corner or congenital cochlear pathology; not using ototoxic medicine; and not having other major pathologies (such as diabetes mellitus).
Ethics committee approval was obtained, and the study was conducted in accordance with the Helsinki Declaration. Informed consent was obtained from the parents of the participants.
Audiometric examinations were performed in quiet rooms with an Interacoustics AC-40 clinical audiometer. Pure-tone averages (PTAs) in the audiogram before treatment and 1 month after treatment were classified according to Siegel criteria (Table 1 ) [7] . Then, patients were divided into two groups: those who recovered (complete+par-tial+mild) group and those who did not.
Blood samples were taken before the initiation of treatment. Hemogram was performed using peripheral venous blood samples obtained at admission. Blood samples were collected into tubes containing calcium ethylenediaminetetraacetic acid. These blood samples were tested using an automated blood cell counter (Beckman Coulter analyzer, CA, United States). The NLR and PLR were calculated as ratios between the absolute neutrophil and absolute lymphocyte counts and between the absolute platelet and absolute lymphocyte counts, respectively.
All patients started 1 miligram/kilogram prednisolone with decreasing doses for at least 2 weeks.
Statistical Analysis
Statistical analysis of data was performed using the SPSS ® 20.0 software (SPSS Inc.; Chicago, IL, USA). For the evaluation of the relationship between the groups, Pearson's chi-square test and Fisher's exact test were used. Statistically, p<0.05 was considered as significant.
RESULTS
There was no statistically significant difference between the patient and control groups in terms of age and gender (p=0.572 and p=0.324, respectively). Those in the patient and control groups were divided into three groups according to their age: 0-5 years (group 1), 6-10 years (group 2), and 11-18 years (group 3). In the patient group, there was 1 patient in group 1, five in group 2, and 15 in group 3; in the control group, there were 2 individuals in group 1, 6 in group 2, and 14 in group 3. There was no statistically significant difference between the patient and control groups in terms of age (p=0.84).A statistical significance was detected between the patient and control groups in terms of the NLR (p<0.05), but there was no statistical significance in terms of the PLR (p>0.05) ( Table 2 ).
The mean PTA of patients before treatment was 54.8±36.4 dB. One month after treatment, the mean PTA of patients who recovered was 18.5±12.2 dB and of those who did not recover was 59.4±30.6 dB.
In the first month after treatment, full (complete) recovery in 6 (28.5%) patients, partial recovery in 4 (19.4%), and mild recovery in 2 (9.52%) were observed in the audiograms. There was no recovery in 9 (42.85%) patients. There was no statistically significant difference in terms of age and gender between patients who recovered and those who did not (p=0.344 and p=0.181, respectively). A statistical significance was detected between patients who recovered and those who did not in terms of the NLR (p<0.05), but there was no statistical significance in terms of the PLR (p>0.05) ( Table 3 ). The NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; SD: standard deviation sensitivity, specificity, and cut-off of NLRs between the patient and control groups were 84.71, 100, and 2.66, respectively ( Figure 1 ). The sensitivity, specificity, and cut-off of NLRs between patients who recovered and those who did not were 83.33, 88.89, and 4.02, respectively ( Figure 2 ).
DISCUSSION
There is limited information in the literature about SHL in a pediatric population. Besides, its incidence is not exactly known because of the difficulties in performing an audiological evaluation in infants and young children. In a study, 3.5% of pediatric patients with SHL were reported to be younger than 14 years. Besides, there is not too much information available about its etiology. It is thought to be caused by reasons such as cochlear perfusion defects and infectious, immunological, and inflammatory causes [8, 9] . Some studies are particularly focused on the relationship between chronic inflammation and cochlear injury, and they found that inflammatory markers are related to ISHL prognosis [10] . High levels of neutrophils can cause endothelial damage; they lead to the impairment of microcirculation and play an important role in the production of cytokines in the inflammatory process. Besides, apoptosis of lymphocytes occurs during inflammation and causes reduction in the number of lymphocytes. Likewise, high levels of platelets can cause vascular occlusion and perfusion problems [6, 11] . NLRs and PLRs are defined as novel potential markers in oncologic, cardiac, cerebrovascular, and renal diseases; Alzheimer's disease; and many inflammatory diseases such as ulcerative colitis, and they are detected to be as valuable as expensive markers such as interleukin (IL)-6, IL-8, IL-1b, and tumor necrosis factor-alpha [12] . The increase in the NLR has been shown to be associated with elevated levels of inflammation [13] . Masuda et al. [14] and Ulu et al. [10] have shown that the NLR was statistically higher in adult patients who were diagnosed with ISHLthan in those in a healthy group. Besides, the NLR was statistically higher in patients who did not recover than in those who recovered.
An increased PLR is associated with critical limb ischemia and vascular diseases such as atherosclerosis [15] . Durmuş et al. [12] and Seo et al. [6] observed that the PLR was significantly higher in adult patients with ISHL than in those in the healthy group. Likewise, the PLR in patients who did not recover was statistically higher than that in those who recovered.
Lee et al. [9] found that that the NLR was statistically higher in pediatric patients with SHL than in those in the healthy group. PLRs were also higher in pediatric patients with SHL than in the healthy group, but they were not statistically significant. No comparison was conducted between patients who recovered and those who did not.
In this study, we investigated the NLR and PLR in 21 pediatric patients with ISHL. The NLR in the healthy pediatric population was lower than that in a pediatric population with ISHL, andthis difference was statistically significant. It was higher in patients who did not recover than in those who recovered 1 month after treatment, and this difference was statistically significant. On the other hand, the PLR was lower in the control group than in the group, but this difference was not statistically significant. In patients who recovered, the PLR was significantly lower than that in patients who did not recover, but this difference was also not statistically significant. The results of our study are similar to those obtained by Lee et al. [9] . The statistical significance of the PLR in adult patients with ISHL compared to pediatric patients with ISHL may be related to age-dependent changes in the PLR and inadequate elevation of PLR value in pediatric patients with ISHL [16] .
In the present study, we detected that an increase in NLR can be used as a cheap and an easily detectable prognostic marker in a pediatric population with ISHL, similar to its use in adult patients. Besides, the relationship between the NLR and recovery supports the chronic inflammation theory in ISHL etiology. The relationship observed between ISHL prognosis and the PLR in adult patients was not detected 
